Brief: Aim Vaccine Says HY Revenue RMB540.5 Million, Down 8.6%
29/08/2023 15:41
Aug 29 (Reuters) - AIM Vaccine Co Ltd 6660.HK :
* HY REVENUE RMB540.5 MILLION, DOWN 8.6%
* HY LOSS ATTRIBUTABLE RMB250.4 MILLION VERSUS LOSS RMB44.9
MILLION
Source text for Eikon: ID:nHKS9QfZ2F
Further company coverage: 6660.HK
Recent news on AIM Vaccine
See all newsBrief: AIM Vaccine Co Submits Application For Human Diploid Cell Rabies Vaccine In China
Brief: AIM Vaccine Says Tibet Bohai To Subscribe 37.4 Million Shares At RMB1.07 Each
Brief: AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares
Brief: Aim Vaccine Says Serum-Free Rabies Vaccine Passes Inspection
Brief: AIM Vaccine Updates On 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine